Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 African trypanosomiasis 💬
[4] IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2 African trypanosomiasis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
3 African trypanosomiasis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
4 African trypanosomiasis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
5 African trypanosomiasis 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
6 AGE-RAGE signaling pathway in diabetic complications 💬
[5] CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
7 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
8 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
9 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
10 AGE-RAGE signaling pathway in diabetic complications 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
11 Alcoholic liver disease 💬
[3] IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
12 Alcoholic liver disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
13 Alcoholic liver disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
14 Alcoholic liver disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
15 Alcoholic liver disease 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
16 Alzheimer disease 💬
[4] IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
17 Alzheimer disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
18 Alzheimer disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
19 Alzheimer disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
20 Alzheimer disease 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
21 Amoebiasis 💬
[4] IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
22 Amoebiasis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
23 Amoebiasis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
24 Amoebiasis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
25 Amoebiasis 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
26 Antifolate resistance 💬
[3] IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
27 Antifolate resistance 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
28 Antifolate resistance 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
29 Antifolate resistance 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
30 Antifolate resistance 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
31 C-type lectin receptor signaling pathway 💬
[4] IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
32 C-type lectin receptor signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
33 C-type lectin receptor signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
34 C-type lectin receptor signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
35 C-type lectin receptor signaling pathway 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
36 Cellular senescence 💬
[2] IL1A, IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
37 Cellular senescence 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
38 Cellular senescence 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
39 Cellular senescence 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
40 Cellular senescence 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
41 Chagas disease 💬
[5] CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
42 Chagas disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
43 Chagas disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
44 Chagas disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
45 Chagas disease 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
46 Coronavirus disease - COVID-19 💬
[4] CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
47 Coronavirus disease - COVID-19 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
48 Coronavirus disease - COVID-19 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
49 Coronavirus disease - COVID-19 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
50 Coronavirus disease - COVID-19 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
51 Coronavirus disease - COVID-19 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
52 Coronavirus disease - COVID-19 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
53 Coronavirus disease - COVID-19 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
54 Cytokine-cytokine receptor interaction 💬
[6] CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
55 Cytokine-cytokine receptor interaction 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
56 Cytokine-cytokine receptor interaction 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
57 Cytokine-cytokine receptor interaction 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
58 Cytokine-cytokine receptor interaction 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
59 Cytokine-cytokine receptor interaction 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
60 Cytokine-cytokine receptor interaction 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
61 Cytokine-cytokine receptor interaction 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
62 Cytosolic DNA-sensing pathway 💬
[2] IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
63 Cytosolic DNA-sensing pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
64 Cytosolic DNA-sensing pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
65 Cytosolic DNA-sensing pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
66 Cytosolic DNA-sensing pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
67 EGFR tyrosine kinase inhibitor resistance 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
68 EGFR tyrosine kinase inhibitor resistance 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
69 EGFR tyrosine kinase inhibitor resistance 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
70 EGFR tyrosine kinase inhibitor resistance 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
71 EGFR tyrosine kinase inhibitor resistance 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
72 EGFR tyrosine kinase inhibitor resistance 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
73 EGFR tyrosine kinase inhibitor resistance 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
74 EGFR tyrosine kinase inhibitor resistance 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
75 Epstein-Barr virus infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
76 Epstein-Barr virus infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
77 Epstein-Barr virus infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
78 Epstein-Barr virus infection 💬
[2] IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
79 Epstein-Barr virus infection 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
80 FoxO signaling pathway 💬
[2] IL10, IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
81 FoxO signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
82 FoxO signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
83 FoxO signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
84 FoxO signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
85 Graft-versus-host disease 💬
[4] IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
86 Graft-versus-host disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
87 Graft-versus-host disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
88 Graft-versus-host disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
89 Graft-versus-host disease 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
90 Hematopoietic cell lineage 💬
[4] IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
91 Hematopoietic cell lineage 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
92 Hematopoietic cell lineage 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
93 Hematopoietic cell lineage 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
94 Hematopoietic cell lineage 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
95 Hematopoietic cell lineage 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
96 Hematopoietic cell lineage 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
97 Hematopoietic cell lineage 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
98 Hepatitis B 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
99 Hepatitis B 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
100 Hepatitis B 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
101 Hepatitis B 💬
[2] IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
102 Hepatitis B 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
103 Herpes simplex virus 1 infection 💬
[4] CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
104 Herpes simplex virus 1 infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
105 Herpes simplex virus 1 infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
106 Herpes simplex virus 1 infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
107 Herpes simplex virus 1 infection 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
108 HIF-1 signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
109 HIF-1 signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
110 HIF-1 signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
111 HIF-1 signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
112 HIF-1 signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
113 HIF-1 signaling pathway 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
114 HIF-1 signaling pathway 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
115 HIF-1 signaling pathway 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
116 Human cytomegalovirus infection 💬
[4] CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
117 Human cytomegalovirus infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
118 Human cytomegalovirus infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
119 Human cytomegalovirus infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
120 Human cytomegalovirus infection 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
121 Human cytomegalovirus infection 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
122 Human cytomegalovirus infection 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
123 Human cytomegalovirus infection 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
124 Human T-cell leukemia virus 1 infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
125 Human T-cell leukemia virus 1 infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
126 Human T-cell leukemia virus 1 infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
127 Human T-cell leukemia virus 1 infection 💬
[2] IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
128 Human T-cell leukemia virus 1 infection 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
129 Hypertrophic cardiomyopathy 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
130 Hypertrophic cardiomyopathy 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
131 Hypertrophic cardiomyopathy 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
132 Hypertrophic cardiomyopathy 💬
[2] IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
133 Hypertrophic cardiomyopathy 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
134 IL-17 signaling pathway 💬
[4] CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
135 IL-17 signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
136 IL-17 signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
137 IL-17 signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
138 IL-17 signaling pathway 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
139 Inflammatory bowel disease 💬
[5] IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
140 Inflammatory bowel disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
141 Inflammatory bowel disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
142 Inflammatory bowel disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
143 Inflammatory bowel disease 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
144 Influenza A 💬
[5] CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
145 Influenza A 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
146 Influenza A 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
147 Influenza A 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
148 Influenza A 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
149 Insulin resistance 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
150 Insulin resistance 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
151 Insulin resistance 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
152 Insulin resistance 💬
[2] IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
153 Insulin resistance 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
154 Intestinal immune network for IgA production 💬
[2] IL10, IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
155 Intestinal immune network for IgA production 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
156 Intestinal immune network for IgA production 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
157 Intestinal immune network for IgA production 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
158 Intestinal immune network for IgA production 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
159 JAK-STAT signaling pathway 💬
[2] IL10, IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
160 JAK-STAT signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
161 JAK-STAT signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
162 JAK-STAT signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
163 JAK-STAT signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
164 JAK-STAT signaling pathway 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
165 JAK-STAT signaling pathway 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
166 JAK-STAT signaling pathway 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
167 Kaposi sarcoma-associated herpesvirus infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
168 Kaposi sarcoma-associated herpesvirus infection 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
169 Kaposi sarcoma-associated herpesvirus infection 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
170 Kaposi sarcoma-associated herpesvirus infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
171 Kaposi sarcoma-associated herpesvirus infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
172 Legionellosis 💬
[3] IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
173 Legionellosis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
174 Legionellosis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
175 Legionellosis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
176 Legionellosis 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
177 Lipid and atherosclerosis 💬
[4] CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
178 Lipid and atherosclerosis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
179 Lipid and atherosclerosis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
180 Lipid and atherosclerosis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
181 Lipid and atherosclerosis 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
182 Malaria 💬
[5] CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
183 Malaria 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
184 Malaria 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
185 Malaria 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
186 Malaria 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
187 Measles 💬
[3] IL1A, IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
188 Measles 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
189 Measles 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
190 Measles 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
191 Measles 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
192 NOD-like receptor signaling pathway 💬
[4] CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
193 NOD-like receptor signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
194 NOD-like receptor signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
195 NOD-like receptor signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
196 NOD-like receptor signaling pathway 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
197 Non-alcoholic fatty liver disease 💬
[4] IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
198 Non-alcoholic fatty liver disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
199 Non-alcoholic fatty liver disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
200 Non-alcoholic fatty liver disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
201 Non-alcoholic fatty liver disease 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
202 Non-alcoholic fatty liver disease 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
203 Non-alcoholic fatty liver disease 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
204 Non-alcoholic fatty liver disease 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
205 Pathogenic Escherichia coli infection 💬
[3] IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
206 Pathogenic Escherichia coli infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
207 Pathogenic Escherichia coli infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
208 Pathogenic Escherichia coli infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
209 Pathogenic Escherichia coli infection 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
210 Pathways in cancer 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
211 Pathways in cancer 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
212 Pathways in cancer 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
213 Pathways in cancer 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
214 Pathways in cancer 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
215 Pathways in cancer 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
216 Pathways in cancer 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
217 Pathways in cancer 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
218 Pathways of neurodegeneration - multiple diseases 💬
[4] IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
219 Pathways of neurodegeneration - multiple diseases 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
220 Pathways of neurodegeneration - multiple diseases 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
221 Pathways of neurodegeneration - multiple diseases 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
222 Pathways of neurodegeneration - multiple diseases 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
223 Pertussis 💬
[5] IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
224 Pertussis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
225 Pertussis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
226 Pertussis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
227 Pertussis 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
228 PI3K-Akt signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
229 PI3K-Akt signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
230 PI3K-Akt signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
231 PI3K-Akt signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
232 PI3K-Akt signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
233 PI3K-Akt signaling pathway 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
234 PI3K-Akt signaling pathway 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
235 PI3K-Akt signaling pathway 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
236 Prion disease 💬
[4] IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
237 Prion disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
238 Prion disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
239 Prion disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
240 Prion disease 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
241 Rheumatoid arthritis 💬
[5] CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
242 Rheumatoid arthritis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
243 Rheumatoid arthritis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
244 Rheumatoid arthritis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
245 Rheumatoid arthritis 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
246 Salmonella infection 💬
[3] IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
247 Salmonella infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
248 Salmonella infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
249 Salmonella infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
250 Salmonella infection 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
251 Th17 cell differentiation 💬
[2] IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
252 Th17 cell differentiation 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
253 Th17 cell differentiation 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
254 Th17 cell differentiation 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
255 Th17 cell differentiation 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
256 Th17 cell differentiation 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
257 Th17 cell differentiation 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
258 Th17 cell differentiation 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
259 TNF signaling pathway 💬
[4] CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
260 TNF signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
261 TNF signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
262 TNF signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
263 TNF signaling pathway 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
264 Toll-like receptor signaling pathway 💬
[3] IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
265 Toll-like receptor signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
266 Toll-like receptor signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
267 Toll-like receptor signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
268 Toll-like receptor signaling pathway 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
269 Transcriptional misregulation in cancer 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
270 Transcriptional misregulation in cancer 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
271 Transcriptional misregulation in cancer 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
272 Transcriptional misregulation in cancer 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
273 Transcriptional misregulation in cancer 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
274 Tuberculosis 💬
[5] IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
275 Tuberculosis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
276 Tuberculosis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
277 Tuberculosis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
278 Tuberculosis 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
279 Viral protein interaction with cytokine and cytokine receptor 💬
[4] CCL2, IL10, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
280 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
281 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
282 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
283 Viral protein interaction with cytokine and cytokine receptor 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬
284 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
285 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [3] 11, 13, 86 💬
286 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [21]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
287 Yersinia infection 💬
[5] CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
288 Yersinia infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
289 Yersinia infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
290 Yersinia infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
291 Yersinia infection 💬
[2] IL6, TNF 💬 Pomalidomide 💬 Pomalidomide [5] 28, 51, 85, 227, 331 💬